May 28, 2025

Kennedy Proposes NIH Publishing Ban

"We're probably going to stop publishing in The Lancet, New England Journal of Medicine, JAMA, and those other journals because they're all corrupt."

Conexiant

May 28, 2025

Statins Recommended for HIV Patients at Risk for Heart Disease

Guidelines from the Department of Health and Human Services recommend statins as primary prevention for people with HIV aged 40 to 75 years who have a 10-year ASCVD risk of 5% or higher.

Conexiant

May 27, 2025

Minimally Invasive Option for Severe Mitral Annular Calcification

The FDA has approved Abbott’s Tendyne system, the first transcatheter mitral valve replacement for patients with severe mitral annular calcification who are ineligible for open-heart surgery.

Conexiant

May 23, 2025

Patients With Psoriasis Show Inflammation Despite Skin Clearance

Over one-third of psoriasis patients had elevated hs-CRP despite biologic treatment and skin clearance, with obesity, female sex, and fatty liver disease identified as key predictors of residual inflammation.

Conexiant

May 23, 2025

BP Pills: Does Timing Matter? 

A large Canadian study of 3,357 patients found that taking blood pressure medication at bedtime did not reduce deaths or heart events compared to morning dosing.

Conexiant

May 23, 2025

BMI, Glucose, Blood Pressure Linked to Multimorbidity

A 30-year cohort study found that life-course factors—including BMI, blood pressure, and glucose—significantly influence chronic disease accumulation, but much of the risk remains unexplained.

Conexiant

May 22, 2025

Voices on the Go: Top Podcasts for Physicians

Physicians are tuning to podcasts that combine clinical insight, career development, and storytelling.

Conexiant

May 20, 2025

Pregnancy Heart Risks Linked to Child BP

Maternal obesity, gestational diabetes, and hypertensive disorders in pregnancy were linked to higher blood pressure in children from age 2 to 18, a study of over 12,000 mother-child pairs found.

Conexiant

May 20, 2025

FDA Releases Guidance to Accelerate Generic Drugs

The new guidance is intended to “foster drug product development, ANDA submission and approval, and ultimately provide increased access to generic drugs."

Conexiant